EcoDrugPlus

Ensembl ID : ML375927a
Gene Symbol: -
External references: -
309 Possible Orthologues:

Ensembl ID : ML38528a
Gene Symbol: -
External references: -
185 Possible Orthologues:

Ensembl ID : ML40945a
Gene Symbol: -
External references: -
183 Possible Orthologues:

Ensembl ID : ML40981a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML40982a
Gene Symbol: -
External references: -
89 Possible Orthologues:

Ensembl ID : ML41321a
Gene Symbol: -
External references: -
83 Possible Orthologues:

Ensembl ID : ML41322a
Gene Symbol: -
External references: -
89 Possible Orthologues:

Ensembl ID : ML418210a
Gene Symbol: -
External references: -
91 Possible Orthologues:

Ensembl ID : ML418612a
Gene Symbol: -
External references: -
54 Possible Orthologues:

Ensembl ID : ML43115a
Gene Symbol: -
External references: -
182 Possible Orthologues:

Ensembl ID : ML43437a
Gene Symbol: -
External references: -
58 Possible Orthologues:

Ensembl ID : ML43582a
Gene Symbol: -
External references: -
259 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).